Results for "Mounjaro"

The US Food and Drug Administration has approved Eli Lilly's diabetes drug Mounjaro to reduce cardiovascular risk, expanding its approved therapeutic uses beyond blood sugar management.

South Korea has seen a significant increase in the unauthorized import of popular weight-loss drugs like Wegovy and Mounjaro, with illegal imports more than tripling in the first half of the year. This surge highlights growing demand and regulatory challenges in the market for these medications.

Celebrities like Chrissy Metz and Serena Williams are among those discussing the use of GLP-1 weight loss injectables such as Ozempic, Mounjaro, and Wegovy, highlighting the public's growing engagement with these medications.

A London law student died in halls of residence after taking Tirzepatide, a weight loss drug prescribed as Zepbound in the US and Mounjaro in the UK, an inquest was told.

Cardiologists are providing insights into the potential effects and outcomes for patients who discontinue the use of popular weight-loss and diabetes medications, Ozempic and Mounjaro.

Danish manufacturer Novo Nordisk announced it is seeking a provisional injunction from a US court to immediately block advertisements for obesity and diabetes drugs by American company Eli Lilly. The lawsuit involves popular medications like Wegovy, Ozempic, Mounjaro, and Zepbound.

An analysis suggests that GLP-1 weight-loss medications like Wegovy and Mounjaro could significantly decrease the risk of alcohol-related hospital admissions by 26%.

A Romanian doctor and professor of Diabetes and Nutrition discusses five effective strategies for weight loss that individuals can pursue before considering medications like Ozempic or Mounjaro.

A new comparative analysis of Ozempic-family drugs reveals that while some are highly effective for weight loss, they may also cause more frequent adverse effects and do not always correlate with greater evidence for reducing heart attacks, deaths, or protecting kidneys, building on previous discussions about their varying efficacy.

Scientists at the Endocrine Society congress presented a systematic review of clinical studies, revealing a new groundbreaking effect of weight-loss drugs like Ozempic, Wegovy, and Mounjaro in men, beyond their primary role in weight reduction.

Drugs such as Ozempic, Mounjaro, and Wegovy are showing effects well beyond weight loss and diabetes treatment, NOS

Davor Skeledžija, from the Association for the Promotion of Patient Education, participated in a European Parliament event on obesity. The discussion highlighted that France covers Mounjaro and Wegovy, Italy has enacted an obesity law, while Croatia is lagging in its approach.

Manufacturer Eli Lilly has offered a significant price reduction for the drug Mounjaro, which may result in the medicine being deemed cost-effective by the National Centre for Pharmacoeconomics.

Anti-obesity centers in France are bracing for a surge in new patients following the June 15 decision to reimburse Wegovy and Mounjaro by social security under strict conditions.

As appetite significantly decreases with Ozempic and Mounjaro use, proper nutrition becomes more vital than ever to optimize results and maintain health.

Japan's Health Minister Ueno called for the proper use of the type 2 diabetes drug Mounjaro, citing concerns over its increasing use for weight loss and potential health risks from side effects.

Japanese medical societies and pharmaceutical companies are issuing warnings against the use of the Type 2 diabetes drug Mounjaro for weight loss purposes, citing potential health risks despite its promotion on social media and by beauty clinics.

The South Korean government is moving to tighten access to injectable obesity medications like Wegovy and Mounjaro, closing prescription loopholes and cracking down on overseas purchases due to misuse concerns.

Scientists have discovered that GLP-1 based medications, such as Ozempic, Wegovy, and Mounjaro, significantly reduce the risk of cardiovascular events like heart attacks and strokes, in addition to their known benefits for diabetes and obesity.

Following the success of Eli Lilly's Mounjaro, Korean drugmakers are intensifying efforts to develop monthly obesity shots, aiming for less frequent injections in the competitive market.

Eli Lilly has significantly increased its market share in the GLP-1 segment, with Mounjaro's revenue soaring by 125%. The company now holds 60% of the GLP-1 market.

Two individuals have been arrested in connection with the manufacturing of fake Mounjaro injections in a Gurugram flat, prompting a nationwide alert and ongoing investigation.

India is examining the potential impact of new weight-loss drugs such as Ozempic and Mounjaro, considering if this marks a significant shift in the country's approach to obesity treatment.

New research indicates that adults using weight-loss medications such as Ozempic or Mounjaro are prone to nutritional deficiencies, including protein, due to significantly reduced food consumption.

In India, weight-loss injections like Mounjaro are reportedly becoming a part of pre-wedding preparations for 'Mounjaro brides,' reflecting evolving beauty standards and trends.

Weight-loss injections, such as Mounjaro, are becoming a popular trend for future brides and grooms in India seeking quick solutions before their wedding day.

In India, weight-loss injections like Mounjaro are becoming a part of pre-wedding preparations for brides, who cite intense scrutiny from arranged marriages and societal body-shaming as reasons.

A Croatian HZZO committee is set to decide today whether to include Mounjaro on the list of subsidized medications for type 2 diabetes patients, potentially making it more accessible.

The weight loss jabs Ozempic, Mounjaro and Weg­ovy — a type of medicine containing semaglutide — are increasingly being seen as a medical wonder of the age.

Data from the National Association of Pharmacies indicates a significant increase in obesity medication sales in 2025, largely driven by the market entry of Mounjaro and Wegovy in Portugal.

This article explains the mechanisms of action for popular weight-loss drugs like Mounjaro and Wegovy, detailing how they work and their current availability to patients through the NHS and private markets.

Bid to improve access to Mounjaro in England, but experts warn eligibility still tightly restricted.

The FDA has approved an expanded indication for Eli Lilly's Mounjaro, allowing its use specifically to lower cardiovascular risk in eligible patients.

Researchers at UC Berkeley have identified a potential new treatment for obesity and diabetes that works by boosting internal metabolism, offering a different mechanism compared to GLP-1 drugs like Ozempic and Mounjaro.

A Romanian IT professional discusses her positive experience using the weight-loss drug Mounjaro, while a doctor addresses online campaigns against such medications.

Germany is discussing whether health insurance should cover weight-loss injections like Wegovy, Mounjaro, and Ozempic, with experts advocating for a relaxation of current regulations.

Comedian Amy Schumer has received praise for sharing unfiltered bikini photos, openly discussing her weight loss journey which she attributes to Mounjaro and hormone therapy for perimenopause symptoms, with new photos showcasing her post-weight loss look.

The Guardian is seeking input from readers who have used GLP-1 drugs such as Wegovy and Mounjaro for weight loss but have not experienced the desired effects, acknowledging that these drugs are ineffective for a small percentage of users.

Actress and TV host Rosie O'Donnell spoke about her experience using weight-loss medication, specifically Mounjaro, stating it "saved her life" after years of struggling with weight gain following her mother's death.

Rosie O'Donnell shared her experience with the drug Mounjaro, which helped her lose 27 kg, after a director told her she needed to lose weight. She recounted the incident and her response to the body-shaming comment.

An opinion piece discusses the negative consequences of using weight-loss injections like Mounjaro, Wegovy, and Ozempic, highlighting risks such as damaged metabolism and muscle loss despite initial weight reduction.

The demand for weight loss medications is expected to increase significantly with the introduction of pill forms, such as Wegovy, in addition to existing injectable treatments like Ozempic and Mounjaro. The article discusses how these drugs work and their associated risks.

An article explores the mechanisms of action for popular weight-loss drugs like Ozempic and Mounjaro, also detailing what happens when individuals stop taking them.

A Gurugram court has denied bail to the alleged mastermind behind a counterfeit Mounjaro drug racket, citing the grave nature of the allegations. The decision underscores the seriousness of the charges in the case.

Hundreds of thousands of people in the Netherlands are using GLP1 medicines like Ozempic or Mounjaro for weight loss, with a significant portion obtaining them without a prescription.

Comedian Alison Spittle shares a personal perspective on the cost of Mounjaro at €350 a month, questioning its value as an investment for health and self-esteem.

The anti-obesity medications Mounjaro and Wegovy are becoming more prevalent in France, now covered by social security for individuals with obesity or diabetes.

The misuse of the diabetes drug Mounjaro for weight loss among women in Japan, one of the world's leanest nations, has ignited a health debate.

New research and debate highlight the potential risks of rapid weight loss, particularly with GLP-1 drugs like Mounjaro, which can lead to significant muscle loss and a higher percentage of body fat, despite overall weight reduction. The article investigates the changes occurring beyond the scale.

New research indicates that the reduction in obesity-related disease risk is directly tied to the amount of weight lost using GLP-1 drugs, such as Ozempic. Additionally, Lilly's Mounjaro has been found to outperform other GLP-1s for some type 2 diabetes patients.

An egg-and-oil recipe is gaining traction in Korea as a cheaper alternative to weight-loss injections like Wegovy and Mounjaro, circulating widely on social media.

Eli Lilly's new obesity drug has demonstrated superior efficacy in trials, helping patients lose over 30% of their body weight and surpassing the performance of Ozempic and Mounjaro.

The President of Romania's National Medicines Agency discussed the complex scheme behind counterfeit Mounjaro, a frequently used drug, being sold at a quarter of its price, warning of severe health risks.

A doctor reported a patient not losing weight on Mounjaro, which was later linked to a fake drug bust. The incident has prompted calls for an advisory to help identify authentic medication.

Authorities have busted a sophisticated racket operating out of a Gurgaon flat that was producing and distributing fake Mounjaro weight loss drugs, with a target of earning significant profits.

An illegal consignment of the obesity drug Mounjaro was seized in Haryana, India, leading to the arrest of two men. Preliminary verification revealed differences from the original manufacturer's product.

New research indicates that an individual's genetic makeup, specifically variations in two genes linked to appetite and digestion, could be a determining factor in the effectiveness of popular weight loss medications such as Wegovy, Mounjaro, and Ozempic.

Research suggests that an individual's genetic predisposition can play a role in how effectively weight-loss medications such as Wegovy and Mounjaro work, with some people losing less weight even with medication.

Novo and Lilly launched their obesity drugs in India last year. The market is forecast to reach ₹80 billion ($851.79 million) by 2030.

Weight-loss injections, such as Mounjaro, are reportedly becoming a popular part of pre-wedding preparations for brides in India.

Drugs like Ozempic, Wegovy, or Mounjaro have changed the game. In some patients, they lead to weight loss, which was practically unattainable without surgery until recently.

GPs in England will receive a £3,000 bonus to increase prescriptions of weight loss drugs like Mounjaro, aiming to improve access despite tight eligibility restrictions.

It will improve competition, an obesity doctor says, but will cost hundreds a month.

A coroner has raised doubts regarding a grandmother's death and is investigating a possible connection to the drug Mounjaro.

The Health and Youth Care Inspectorate in the Netherlands has imposed significant fines on several Dutch media outlets for their coverage of GLP1 medicines like Ozempic, Wegovy, and Mounjaro, deeming it "promoting."

Actress Rosie O'Donnell stated she feels "never felt better" at 64, partly crediting the drug Mounjaro for her improved health.

The UK's medicines regulator is investigating nearly 200 deaths potentially associated with weight-loss drugs Ozempic and Mounjaro. This comes after reports of over 150 deaths linked to slimming injections.

Comedian Amy Schumer has received praise for sharing unfiltered bikini photos, openly discussing her weight loss journey which she attributes to Mounjaro and hormone therapy for perimenopause symptoms.

Reports of side effects such as 'Ozempic face,' hair loss, and digestive problems are increasing as weight-loss medications like Wegovy and Mounjaro gain popularity, prompting research into their robustness.

A new simulation illustrates the physiological effects of weight-loss injections, such as Mounjaro, within the body. These medications are shown to slow digestion and regulate blood sugar levels.

This article provides a comparison between Victoza and Mounjaro, two prominent medications used for weight management. It highlights their differences and potential uses.

An opinion piece and recent reports highlight various negative consequences of using weight-loss injections such as Mounjaro, Wegovy, and Ozempic, including risks like damaged metabolism, muscle loss, and newly identified side effects like 'Ozempic feet'.

Burglars have been sentenced to jail after being caught stealing £1 million worth of the weight-loss drug Mounjaro from a warehouse, returning for more boxes less than two hours after their initial theft.

Weight-loss drugs like Ozempic and Mounjaro have emerged as Britain's latest cultural divide, replacing Brexit with a fresh wave of judgment, stigma, and shame.

A podcast discusses the 'bycatch' or additional effects of weight-loss medications like Ozempic, Mounjaro, and Wegovy. Users report experiencing more than just reduced hunger and weight loss, indicating broader impacts.

Eli Lilly, maker of Mounjaro, is deploying its weight-loss drug profits to create an 'App Store' for scientists, collaborating with small biotechs to utilize AI as a tool for drug discovery.

The French healthcare system is now reimbursing anti-obesity drugs like Wegovy and Mounjaro under strict conditions, prompting discussions on France's obesity rates and affected regions.

Researchers are continually discovering new applications for GLP-1 agonist drugs like Mounjaro and Ozempic, with recent findings suggesting potential as a treatment for substance abuse. This highlights the ongoing drug repurposing efforts.

A new test helps individuals determine their candidacy for prescription weight-loss drugs like Ozempic, Wegovy, and Mounjaro, which are now available for diabetes and obesity treatment.

Osaka police have referred three individuals to prosecutors for allegedly selling the weight-loss drug Mounjaro in violation of pharmaceutical laws, with all suspects admitting to the charges.

The anti-obesity medications Wegovy and Mounjaro are expected to be partially covered for patients suffering from severe obesity in France.

GLP-1 drugs, known by names like Ozempic, Wegovy, and Mounjaro, offer benefits to the heart, kidneys, and liver, independent of weight loss. These broader effects, previously observed in animals, are now being seen in humans.

Eli Lilly (LLY) is experiencing robust growth, primarily driven by the momentum of its drug Mounjaro and increasing demand for GLP-1 medications, leading Barclays to maintain a bullish outlook on the company.

The manufacturer of Mounjaro has warned that a counterfeit version of its drug is being sold in Romania as a food supplement, prompting the College of Physicians to intervene due to potential health risks.

Pharmaceutical company Eli Lilly announced strong financial results for the first quarter of 2026, with significant growth attributed to the performance of its key drugs, Mounjaro and Zepbound.

Authorities in Gurugram have busted a racket involved in making and selling fake Mounjaro injections, leading to the arrest of two individuals. The operation targeted the illicit trade of counterfeit weight loss drugs.

GLP-1 medications like Ozempic and Mounjaro, popular for diabetes and obesity treatment, are being examined for their specific effects on the stomach and intestines.

A recent study indicates that an individual's genetic makeup could be a determining factor in the effectiveness of popular weight loss medications such as Mounjaro and Ozempic.

People who carry variations in two genes linked to appetite and digestion can lose more weight when taking drugs to treat obesity, research suggests.

Weight loss injections, dubbed "Mounjaro Brides," are becoming a popular pre-wedding preparation for couples in India seeking quick solutions to slim down before their big day.

A new trend has emerged in India where weight-loss injections, dubbed 'Mounjaro brides,' are becoming a part of pre-wedding preparations for women.

US pharmaceutical giant Eli Lilly is reportedly pushing for higher drug prices from the NHS, linking the increases to its investment plans within the United Kingdom and expressing optimism about ongoing talks with ministers.

When you stop the medication, that food noise returns.

A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.

The article discusses whether popular weight-loss drugs like Ozempic and Mounjaro are covered by insurance in the UAE, a growing concern for patients.

GPs in England will receive a £3,000 bonus to increase prescriptions of weight loss drugs like Mounjaro, aiming to improve access despite ongoing eligibility restrictions.

Eli Lilly is eyeing India as a global export hub for its Mounjaro drug, driven by surging sales.